ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

Novartis Pharmaceuticals · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
metastatic renal cell carcinoma (mrcc), kidney cancer, mrcc, metastic renal cell carcinoma, everolimus, sunitinib, pazopanib, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 829067
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.